SCHEMBL12425356

SCHEMBL12425356

CC(C)(C)OC(=O)NC1CCN(C(=O)c2ccc(N)nc2)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.52
NAMPT P43490 1/20 0.49
HDAC3 O15379 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
CFTR P13569 1/20 0.47
USP30 Q70CQ3 1/20 0.46
CYP2C9 P11712 1/20 0.46
HSD11B1 P28845 1/20 0.46
BTK Q06187 1/20 0.46
ADORA2A P29274 5/20 0.45
ADORA2B P29275 4/20 0.45
ADORA3 P0DMS8 2/20 0.45
CTSK P43235 2/20 0.45
MAP4K4 O95819 2/20 0.44
AKT1 P31749 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CKS1B P61024 1/20 0.44
SKP1 P63208 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24185654 0.88 EPHX2 (0.52) PARP1NAMPTCFTRUSP30CYP2C9
SCHEMBL31267093 0.87 NAMPT (0.57) PARP1NAMPTHDAC3HDAC1HDAC2
SCHEMBL31267054 0.87 NAMPT (0.57) PARP1NAMPTHDAC3HDAC1HDAC2
SCHEMBL14731460 0.82 ADORA2A (0.55) PARP1NAMPTCFTRUSP30CYP2C9
SCHEMBL4616966 0.81 EPHX2 (0.59) PARP1NAMPTCFTRBTKAKT1
SCHEMBL1995443 0.81 MAP4K4 (0.51) HDAC3HDAC1HDAC2BTKCTSK
SCHEMBL30316309 0.81 MAP4K4 (0.51) HDAC3HDAC1HDAC2BTKCTSK
SCHEMBL24185784 0.81 NAMPT (0.56) PARP1NAMPTHDAC3HDAC1HDAC2
SCHEMBL24185232 0.81 NAMPT (0.56) PARP1NAMPTHDAC3HDAC1HDAC2
SCHEMBL24185215 0.81 NAMPT (0.56) PARP1NAMPTHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011101409-A1 PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 NOVARTIS AG (CH) 2011-08-25 WO disclosed